about
The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stressEffect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia.Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis.Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.Toll-like receptor genetic variations in bone marrow transplantation.Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.Upfront allogeneic HCT vs remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: a propensity score matched analysisEstablishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining regionBetter disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary diseaseEfficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agentsPatients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decadesNovel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivoDonor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk PatientsConditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete RemissionAutologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in JapanBicytopenia in Primary Lung Melanoma Treated with Nivolumab
P50
Q33701615-3B01CB89-394D-47BD-87DA-1335C90E02B7Q35088910-3F56BD38-4BA7-4550-8C6C-9B087541FF2EQ38657161-3A83B6A3-7F23-421C-8A1D-4A8E251F5D9DQ38770125-5E17BF20-536C-4655-A813-4A0A84BE022EQ38837700-953B3459-EA53-4127-9D98-701E0A820D5CQ39001495-4D5476CE-90E6-42D1-8B5F-A6FE7CE4BDC8Q39188796-8DAC246E-A6EE-4496-B483-3E81128A2379Q39464494-F51A8375-74AF-4359-9359-05A86CB358A1Q39652880-1D778FDC-7E22-489F-AB55-EA819E0ED3ABQ40208593-F45A6E43-1714-4C30-95FD-648272632C60Q40209654-7722700F-CBC9-430D-871A-3B392FF929A2Q40628153-EACEFE20-FFCA-4ED9-9E0F-9FEB65128773Q41070167-043B56D8-A255-44EB-A36D-4B00C1584FABQ58100092-B3F3C1D5-7175-408B-8FAE-4833F964E156Q59791261-B4FD95E3-AA47-47A7-A423-9BBB9937A581Q64111424-260EA5CE-0E8E-4304-8CCC-E6426B919BF0Q64115736-8818FE7A-6261-4F38-8B37-1471DC90FCB5Q64122847-856F2D45-7693-490F-ADD1-31C3FB999312Q89259988-957BC4F8-2F58-426B-8D01-7C668132A21AQ89719591-07EED2AD-BD1C-4C8D-BAED-B3363478A455Q90343102-A37085A1-D835-4C94-946C-BFE3FFFE9247Q90707612-458558BF-86D2-48C7-A757-CECEFD65BAF4Q93200554-4717ACD3-163D-41C3-AB12-E6400158B5C4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Shohei Mizuno
@en
Shohei Mizuno
@nl
type
label
Shohei Mizuno
@en
Shohei Mizuno
@nl
prefLabel
Shohei Mizuno
@en
Shohei Mizuno
@nl
P31
P496
0000-0002-4405-8808